APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

Two studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate, but ...

EULAR - The European Alliance of Associations for Rheumatology - recommends a treat-to-target approach, and suggests more ...

About one-third of psoriasis sufferers develop psoriatic arthritis, with swelling, tenderness and pain in joints, affecting daily activities and lifestyle. Psoriatic arthritis (PsA) is a chronic ...

A large PsA cohort study found metabolic syndrome linked to spine and enthesis degeneration, but not to radiographic joint ...

Two recent studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate2,3, but these did not ...

The following is a summary of “Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal ...

Enthesitis is a key, but often overlooked, feature of psoriatic arthritis. Learn how this inflammation at tendon and ligament attachment sites can affect diagnosis, symptoms, and treatment.

European researchers unveil digital tools and explainable AI that personalize psoriatic arthritis care, enabling early ...